Clinical Trial Update: A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) [Phase 1]

View source ↗

Summary

A Phase 1 clinical study of TQH2929 Injection for generalized pustular psoriasis is currently active but not recruiting. The sponsor is listed as Chia Tai Tianq…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Pustular Psoriasis

Drugs mentioned

• TQH2929 Injection

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Generalized Pustular Psoriasis | Phase 1 | Status: ACTIVE_NOT_RECRUITING